Skip to content

Senate Council Meeting: “When there is a temporary reduction in Pathology Laboratory capacity, how can pathology demand be managed or reduced with the least possible risk of clinical harm?”

On the 26th November 2020 the Clinical Senate deliberated the questions:

“When there is a temporary reduction in Pathology Laboratory capacity, how can pathology demand be managed or reduced with the least possible risk of clinical harm?

Presentations

Bruce Daniel Pathology Laboratory Capacity in the South West – Clinical senate 26.11.20

Bruce, Pathology Service Manager & South 1 incident director

SW Clinical Senate – Sadie Thomas

Dr Sadie Thomas, Principal Clinical Biochemist, Gloucestershire Royal Hospital

Citizens’ Assembly Contribution

Nick Pennell, Chair of SW Citizens’ Assembly

Agenda

20.11.26 Agenda-Senate Council_

Recommendations

FINAL Clinical Senate Recommendations – Pathology Prioritisation – Nov 26th 2020